Relay Therapeutics, Inc.

RLAYNASDAQHealthcareBiotechnology

$18.12- (-)1Y +171.30%

As of Oct 26, 2026 close

Market cap: $3.68B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $5.95$21.27
Volume (live): -
Avg. volume (3M): 2.93M

Relay Therapeutics, Inc. (RLAY) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Relay Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(14 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$27.14

+44.06% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest RLAY Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 23, 2026	Chi Meng Fong	BofA Securities	Maintains	Buy	$25.00
Oct 12, 2026	Chi Meng Fong	BofA Securities	Maintains	Buy	$25.00
Sep 28, 2026	Boris Peaker	JonesTrading	Maintains	Buy	$20.00
Aug 20, 2026	Robert Burns	HC Wainwright	Reiterates	Buy	$28.00 → $29.00 +1.00 (+3.6%)
Aug 18, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 14, 2026	Priyanka Grover	JP Morgan	Maintains	Buy	$28.00 → $31.00 +3.00 (+10.7%)
Aug 10, 2026	Silvan Tuerkcan	Citizens JMP	Maintains	Buy	$21.00 → $26.00 +5.00 (+23.8%)
Aug 7, 2026	John Newman	Canaccord Genuity	Maintains	Buy	$29.00
Aug 7, 2026	Yaron Werber	TD Cowen	Maintains	Buy	-
Aug 7, 2026	Etzer Darout	Barclays	Maintains	Buy	$27.00 → $30.00 +3.00 (+11.1%)
Aug 7, 2026	Chi Meng Fong	BofA Securities	Reiterates	Buy	$21.00 → $25.00 +4.00 (+19.1%)
Aug 6, 2026	John Newman	Canaccord Genuity	Maintains	Buy	$29.00
Aug 6, 2026	Yaron Werber	TD Cowen	Maintains	Buy	-
Jul 30, 2026	Edmund Ingham	Forbes	Initiates Coverage	Hold	-

Chi Meng Fong

BofA Securities

BuyMaintains

$25.00

Oct 23

Chi Meng Fong

BofA Securities

BuyMaintains

$25.00

Oct 12

Boris Peaker

JonesTrading

BuyMaintains

$20.00

Sep 28

Robert Burns

HC Wainwright

BuyReiterates

$28.00 → $29.00

Aug 20

Zacks Equity Research

HoldInitiates Coverage

Aug 18

Priyanka Grover

JP Morgan

BuyMaintains

$28.00 → $31.00

Aug 14

Silvan Tuerkcan

Citizens JMP

BuyMaintains

$21.00 → $26.00

Aug 10

John Newman

Canaccord Genuity

BuyMaintains

$29.00

Aug 7

Yaron Werber

TD Cowen

BuyMaintains

Aug 7

Etzer Darout

Barclays

BuyMaintains

$27.00 → $30.00

Aug 7

Chi Meng Fong

BofA Securities

BuyReiterates

$21.00 → $25.00

Aug 7

John Newman

Canaccord Genuity

BuyMaintains

$29.00

Aug 6

Yaron Werber

TD Cowen

BuyMaintains

Aug 6

Edmund Ingham

Forbes

HoldInitiates Coverage

Jul 30

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for RLAY?

The analyst consensus rating for RLAY is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for RLAY?

The average 12-month price target for RLAY is $27.14, representing an upside of 44.1% from the Oct 27, 2026 close of $18.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.